Wednesday, June 24, 2020

Zydus Cadila gets USFDA nod to market generic antihistamine tablets

Zydus Cadila gets USFDA nod to market generic antihistamine tablets The company has received final approval from the United States Food and Drug Administration (USFDA) to market Meclizine hydrochloride tablets in the strengths of 12.5 mg and 25 mg, the company said in a statement.

from Moneycontrol Business News https://ift.tt/2YXPC0g
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...